The MondoA dependent relationship between TXNIP and GDF15 in response to oxaliplatin-induced ROS can be used to predict aggression and treatment sensitivity in colorectal adenocarcinoma. This evidence concerns the gene GDF15 and colorectal adenocarcinoma.